• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹膜炎中细菌对抗生素的耐药性生态学及机制]

[Ecology and mechanisms of bacterial resistance to antibiotics in peritonitis].

作者信息

Edern Anita, Fines-Guyon Marguerite, Castrale Cindy, Ficheux Maxence, Ryckelynck Jean-Philippe, Lobbedez Thierry

机构信息

Service de néphrologie-dialyse-transplantation rénale, CHU Clémenceau, avenue G.-Clémenceau, 14033 Caen cedex, France.

出版信息

Nephrol Ther. 2012 Nov;8(6):456-61. doi: 10.1016/j.nephro.2011.12.003. Epub 2012 Feb 10.

DOI:10.1016/j.nephro.2011.12.003
PMID:22326656
Abstract

Peritonitis remains a common complication of peritoneal dialysis. The aim of our study is to describe the mechanisms of antibiotic resistance in bacteria isolated during peritonitis in peritoneal dialysis, to determine whether antibiotic therapy proposed by the International Society for Peritoneal Dialysis (ISPD) is adapted to the mechanisms of resistance. All causative microorganisms of peritonitis, isolated in 106 dialysis patients and reported 170 episodes of peritonitis, during the study period (01/01/2005 to 31/12/2010) were reviewed. According to the usual classification, twelve groups of microorganism were created. An interpretive reading of antibiograms was performed in each group to identify resistance phenotypes. The species most frequently isolated are coagulase-negative staphylococci (n=73) of which 46 had PBP2a (penicillin-binding protein). Many Enterobacteriaceae were also isolated (n=45), they are susceptible to third generation cephalosporins with the exception of Enterobacteriaceae producing an extended spectrum β-lactamase (ESBL) or a cephalosporinase. Except for staphylococci, probabilistic antibiotic therapy recommended by the ISPD to treat peritonitis is effective. Indeed, many staphylococci producing a PBP2a, a first-generation cephalosporin cannot be administered in all cases. It is therefore necessary to identify patients with a strain of staphylococcus producing a PBP2a, it must be treated by vancomycin.

摘要

腹膜炎仍然是腹膜透析的常见并发症。我们研究的目的是描述腹膜透析腹膜炎期间分离出的细菌对抗生素耐药的机制,以确定国际腹膜透析学会(ISPD)推荐的抗生素治疗是否适合耐药机制。回顾了在研究期间(2005年1月1日至2010年12月31日)106例透析患者中分离出的所有腹膜炎致病微生物,并报告了170次腹膜炎发作情况。根据常规分类,创建了十二组微生物。对每组的抗菌谱进行解释性阅读以确定耐药表型。最常分离出的菌种是凝固酶阴性葡萄球菌(n = 73),其中46株具有PBP2a(青霉素结合蛋白)。也分离出许多肠杆菌科细菌(n = 45),除了产生超广谱β-内酰胺酶(ESBL)或头孢菌素酶的肠杆菌科细菌外,它们对第三代头孢菌素敏感。除葡萄球菌外,ISPD推荐的治疗腹膜炎的概率性抗生素治疗是有效的。确实,许多产生PBP2a葡萄球菌的病例不能一概使用第一代头孢菌素。因此,有必要识别出感染产生PBP2a葡萄球菌菌株的患者,这类患者必须用万古霉素治疗。

相似文献

1
[Ecology and mechanisms of bacterial resistance to antibiotics in peritonitis].[腹膜炎中细菌对抗生素的耐药性生态学及机制]
Nephrol Ther. 2012 Nov;8(6):456-61. doi: 10.1016/j.nephro.2011.12.003. Epub 2012 Feb 10.
2
Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.凝固酶阴性葡萄球菌性腹膜炎:头孢菌素耐药菌株的结局
Adv Perit Dial. 2010;26:34-6.
3
[Peritonitis in intermittent peritoneal dialysis: microbiological aspects and the antibiogram].[间歇性腹膜透析中的腹膜炎:微生物学方面及抗菌谱]
Rev Hosp Clin Fac Med Sao Paulo. 1989 May-Jun;44(3):100-3.
4
Microbiology and outcomes of peritonitis in northern India.印度北部腹膜炎的微生物学及预后情况
Perit Dial Int. 2014 Mar-Apr;34(2):188-94. doi: 10.3747/pdi.2012.00233. Epub 2014 Mar 1.
5
Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis.持续性非卧床腹膜透析相关性腹膜炎中凝固酶阴性葡萄球菌的菌种鉴定及药敏分析
J Antimicrob Chemother. 1984 Jun;13(6):577-83. doi: 10.1093/jac/13.6.577.
6
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.腹膜透析相关性腹膜炎患者的病原体谱及耐药性:一项单中心观察性临床研究
Clin Nephrol. 2019 Jul;92(1):44-51. doi: 10.5414/CN109634.
7
Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.产超广谱β-内酰胺酶的肺炎克雷伯菌所致慢性非卧床腹膜透析腹膜炎经多粘菌素B成功治疗
Heart Lung. 2005 Sep-Oct;34(5):360-3. doi: 10.1016/j.hrtlng.2004.11.001.
8
A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?西澳大利亚地区腹膜透析相关性腹膜炎的12个月回顾:某些患者是否仍需经验性使用万古霉素?
Perit Dial Int. 2003 Sep-Oct;23(5):465-8.
9
[Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].[持续性非卧床腹膜透析中的腹膜炎。经验性初始抗生素治疗的评估]
Ugeskr Laeger. 1996 Apr 29;158(18):2532-7.
10
The recommendations from the International Society for Peritoneal Dialysis for Peritonitis Treatment: a single-center historical comparison.国际腹膜透析学会关于腹膜炎治疗的建议:单中心历史对照研究
Adv Perit Dial. 2004;20:74-7.

引用本文的文献

1
Using MALDI-TOF Mass Spectrometry to Identify Drug Resistant Staphylococcal Isolates from Nonhospital Environments in Brunei Darussalam.使用基质辅助激光解吸电离飞行时间质谱法鉴定文莱达鲁萨兰国非医院环境中的耐药物葡萄球菌分离株。
Interdiscip Perspect Infect Dis. 2016;2016:8685602. doi: 10.1155/2016/8685602. Epub 2016 Apr 3.
2
Could public restrooms be an environment for bacterial resistomes?公共卫生间会成为细菌耐药组的滋生环境吗?
PLoS One. 2013;8(1):e54223. doi: 10.1371/journal.pone.0054223. Epub 2013 Jan 17.